Tetanus and Botulism

• Toxin-Mediated Neuromuscular Dysfunction via Proteolytic Cleavage of SNARE Proteins: Both tetanus toxin (tetanospasmin) and botulinum toxins are zinc-dependent endopeptidases that irreversibly cleave soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARE) proteins essential for acetylcholine (ACh) release at the neuromuscular junction. Tetanospasmin cleaves synaptobrevin (VAMP), while botulinum toxins (seven serotypes: A through G) cleave either synaptobrevin, SNAP-25, or syntaxin depending on serotype. This proteolytic destruction prevents the fusion of acetylcholine-containing synaptic vesicles with the presynaptic membrane, blocking neurotransmitter release and producing the characteristic paralysis. The toxins are produced as inactive single-chain proteins that require proteolytic activation; in tetanus, environmental proteases activate the toxin, while in botulism, toxin activation varies by route of acquisition. Once internalized into the nerve terminal, toxin action is essentially irreversible, requiring formation of new nerve terminals through sprouting and acetylcholine receptor restoration—a process requiring weeks to months for clinical recovery.

• Divergent CNS Effects: Tetanus Rigidity vs. Botulism Weakness: Despite structurally similar toxin mechanisms at the neuromuscular junction, tetanus and botulism produce opposite clinical presentations because tetanospasmin affects both motor neurons and inhibitory interneurons, while botulinum toxin primarily affects motor neurons. In tetanus, the toxin's retrograde transport to the spinal cord and brainstem blocks the release of inhibitory neurotransmitters (GABA and glycine) from inhibitory interneurons, leading to unopposed excitatory input and characteristic rigid paralysis or spasticity. Conversely, botulinum toxin's peripheral motor neuron effect produces pure motor paralysis without CNS involvement, resulting in flaccid weakness and descending paralysis. The tetanus toxin's dual action on both excitatory and inhibitory neurons explains why tetanus produces the characteristic "risus sardonicus" (facial rigidity) and "opisthotonus" (severe back arching), while botulism patients remain mentally alert with preserved consciousness and cognitive function.

• Autonomic Instability in Tetanus Through CNS Pathway Disruption: Tetanospasmin's CNS effects extend beyond motor control to disrupt autonomic nervous system balance by impairing inhibitory control of sympathetic outflow in the brainstem and spinal cord. This produces severe dysautonomia characterized by hypertension, tachycardia, hyperthermia, profuse diaphoresis, and potentially fatal arrhythmias. The blockade of inhibitory pathways removes normal suppression of sympathetic tone, resulting in a hyperadrenergic state. This autonomic dysfunction represents the primary cause of death in severe tetanus and distinguishes it pathophysiologically from botulism, where autonomic manifestations (anticholinergic effects) result from peripheral parasympathetic blockade rather than CNS dysregulation.

• Spore Germination and Toxin Production Context: Clostridium tetani produces spores that germinate under anaerobic conditions in contaminated wounds, muscle injury sites, or devitalized tissues; following germination, the vegetative bacteria produce tetanospasmin locally. The toxin then undergoes retrograde axonal transport along motor nerves to reach the spinal cord and brainstem. Clostridium botulinum similarly produces spores that germinate in specific environmental niches: foodborne botulism results from toxin preformed in food items where anaerobic conditions allowed bacterial multiplication and in situ toxin production, while wound botulism results from bacterial proliferation within tissue sites. Infant botulism represents a unique scenario where ingested spores germinate within the infant intestinal tract, with in vivo toxin production. This distinction explains why foodborne botulism has a sudden onset after ingestion of preformed toxin, while wound botulism has a more insidious prodrome reflecting ongoing bacterial toxin synthesis.

TETANUS

• **Wound Contamination with Clostridium tetani Spores**: Tetanus occurs after contamination of wounds with soil or environmental sources containing C. tetani spores, with risk proportional to wound characteristics promoting anaerobic conditions. Puncture wounds (particularly "tetanus-prone" wounds from dirty objects, rusty implements, or animal/human bites), crush injuries, burns, surgical wounds, and injection drug use sites provide ideal anaerobic environments for spore germination. Wounds appearing trivial may harbor tetanus risk; notably, 10-15% of tetanus cases lack identifiable wound history ("cryptogenic tetanus"). Post-operative tetanus occurs after surgical wound contamination, while injection drug use–associated tetanus (particularly from subcutaneous and intramuscular injection) has increased dramatically in recent decades.

• Inadequate Immunization as Primary Risk Factor: The vast majority of tetanus cases globally occur in unvaccinated or inadequately vaccinated individuals; in the United States, >95% of tetanus cases occur in persons with incomplete primary vaccination series or unknown vaccination status. Vaccination failure is rare (~2-3% primary failure rate), but waning immunity after 10 years without booster doses significantly increases risk. Elderly patients represent the highest-risk group in developed countries due to both inadequate childhood vaccination in older cohorts and failure to maintain booster schedules; serological studies indicate >50% of Americans ≥60 years lack protective tetanus antibody levels.

• Conditions Impairing Wound Healing and Immune Response: Diabetes mellitus, malnutrition, immunosuppression (from malignancy, HIV, transplantation), chronic corticosteroid use, and advanced age all increase tetanus risk by impairing immune response to vaccination and by compromising wound healing, thereby prolonging anaerobic wound conditions. Chronic wounds, pressure ulcers, and burns in elderly or immunocompromised patients carry particularly elevated risk.

BOTULISM

• Foodborne Botulism from Improperly Preserved Foods: Botulism results from ingestion of preformed botulinum toxin in foods that underwent inadequate heat processing or preservation, allowing C. botulinum spores to germinate and produce toxin under anaerobic conditions. High-risk foods include home-canned vegetables (particularly low-acid items such as beans and mushrooms), fermented fish products, garlic in oil preparations, and improperly processed meat products. Foodborne botulism typically affects multiple individuals who consumed the same food source; outbreaks most commonly involve non-commercial home canning in developed countries and fermented foods in developing regions.

• Wound Botulism from Tissue Colonization: Wound botulism results from C. botulinum spore colonization and in vivo toxin production within contaminated wounds or injection sites. This form has dramatically increased with intravenous and subcutaneous heroin/opioid use ("skin popping"), particularly with black tar heroin use in North America. Wound botulism may also follow trauma, surgery, or chronic wounds in non-drug-using individuals, though this is rare.

• Infant Botulism from Intestinal Spore Germination: Infants <12 months (particularly <6 months) are uniquely susceptible to botulism after ingesting C. botulinum spores, which germinate within the intestinal tract and produce toxin in vivo. Honey is the classic associated food source, though spores are found in other foods and environmental sources. Infants lack the intestinal flora competence and gut barrier maturation to prevent spore germination, a risk that diminishes dramatically after age 1 year.

• Iatrogenic Botulism from Cosmetic/Therapeutic Botulinum Toxin: Adverse effects from botulinum toxin injections (cosmetic or therapeutic) are rare but result from toxin diffusion beyond intended sites or from excessive dosing, causing clinical botulism characterized by descending paralysis indistinguishable from naturally occurring disease.

TETANUS - Classic "Lockjaw" Presentation

• Trismus (Lockjaw) and Risus Sardonicus: The pathognomonic early sign of tetanus is trismus—masseter muscle rigidity limiting jaw opening—resulting from tetanospasmin's effects on motor neurons innervating mastication muscles. This occurs as spinal cord concentrations of toxin increase, blocking inhibitory input to these muscles. Risus sardonicus (sardonic grin) develops when toxin affects facial muscles, producing characteristic fixed facial expression with retracted lips and wrinkled forehead. These signs typically appear 1-3 days after toxin entry and often precede generalized tetanus, creating diagnostic opportunity if recognized.

• Opisthotonus and Generalized Muscle Rigidity: As toxin concentrations increase, unopposed excitatory drive produces severe sustained contraction of paraspinal muscles ("opisthotonus"—extreme back arching), flexor muscles of the limbs, and trunk muscles. This generalized rigidity is not true spasticity but rather a fixed posture from simultaneous contraction of agonist and antagonist muscle groups due to lost inhibitory control. Patients adopt characteristic "fetal position" with flexed limbs and arched back. This rigidity persists during sleep and under general anesthesia (unlike functional disorders), a key distinguishing feature.

• Autonomic Instability and Dysrhythmias: Severe tetanus is characterized by sympathetic hyperactivity producing hypertension (SBP often >180 mmHg), tachycardia (HR often >120), hyperthermia (core temperature often >39°C), profuse diaphoresis, and life-threatening arrhythmias including sudden asystole, atrial fibrillation, or ventricular fibrillation. Dysautonomia typically manifests during the second week of illness and represents the primary cause of death in modern intensive care settings. The autonomic manifestations reflect brainstem dysfunction with unopposed sympathetic outflow, distinct from the motor manifestations reflecting spinal cord dysfunction.

• Tetanic Spasms (Painful Muscle Contractions): Sudden, violent involuntary muscle contractions ("tetanic spasms") occur spontaneously or triggered by minor sensory stimuli (auditory, tactile, visual). These spasms are excruciatingly painful and may cause rhabdomyolysis with myoglobinuria, fractures from violent contraction force, or aspiration. Spasms reflect hyperexcitability of motor neurons in both spinal cord and brainstem from loss of inhibitory control.

• Preserved Cognition and Consciousness: Unlike many severe neurological emergencies, conscious level is fully preserved in tetanus; patients remain alert and oriented despite severe motor dysfunction. This preserved cognition alongside severe rigidity creates significant psychological distress for patients aware of their paralyzed state, and this feature aids diagnosis when combined with motor findings.

• Clinical Variants:
• Cephalic tetanus: Rare variant following head/facial wounds with earlier onset of facial symptoms and higher mortality
• Neonatal tetanus: Results from umbilical stump contamination in unvaccinated mothers; produces feeding difficulty, weak cry, and poor suck within first 2 weeks of life
• Localized tetanus: Rigidity confined to muscles near wound site; may progress to generalized disease; better prognosis than generalized

BOTULISM - Descending Paralysis Variant

• Diplopia, Blurred Vision, and Ptosis: Botulism characteristically begins with oculomotor dysfunction reflecting the cranial nerve motor involvement typical of descending paralysis. Patients report diplopia or blurred vision from extraocular muscle weakness and progressing ptosis. Unlike other causes of ptosis, this reflects motor paralysis rather than autonomic (Horner's) or neuromuscular (myasthenia) dysfunction.

• Dry Mouth and Bulbar Weakness: Early and prominent anticholinergic manifestations include xerostomia (dry mouth) from salivary gland denervation and bulbar weakness producing dysarthria, dysphonia (classically described as breathy or high-pitched voice), and dysphagia. Gag reflex weakness and inability to swallow secretions increase aspiration risk.

• Descending Paralysis and Flaccid Weakness: Botulism characteristically produces a symmetric descending paralysis pattern beginning with cranial nerves (CN III, IV, VI, VII, IX, X, XII) and proceeding caudally to involve neck, trunk, and finally limb muscles over hours to days. Motor paralysis is flaccid (not rigid as in tetanus), and patients demonstrate normal or diminished deep tendon reflexes. Strength testing shows symmetrical motor weakness; importantly, sensation remains fully intact.

• Autonomic Dysfunction with Parasympathetic Features: Botulism produces anticholinergic autonomic dysfunction (distinct from tetanus's sympathomimetic dysautonomia) manifesting as xerostomia, mydriasis (dilated pupils), decreased sweating, and constipation (not diarrhea). These features reflect parasympathetic blockade rather than sympathetic hyperactivity.

• Respiratory Compromise and Hypercapnic Respiratory Failure: Progressive paralysis of respiratory muscles (diaphragm, intercostals) produces hypercapnic respiratory failure requiring mechanical ventilation in severe cases. Respiratory compromise typically develops later than cranial nerve involvement, providing a temporal window for therapeutic intervention. Patients remain fully alert throughout, increasing psychological distress.

• Preserved Cognition with "Clear Sensorium": Botulism's hallmark is complete preservation of cognitive function, consciousness, and sensation despite severe motor paralysis—creating the clinical paradox of an alert, mentally intact patient with severe motor dysfunction. This feature is critical for diagnosis and distinguishes botulism from other causes of descending paralysis (Guillain-Barré syndrome with altered mental status suggests concurrent CNS infection).

• Clinical Variants:
• Foodborne: Acute onset (12-72 hours post-ingestion) with multiple cases sharing food exposure
• Wound botulism: More insidious onset over 4-10 days with potential for recurrent toxin production from ongoing bacterial proliferation
• Infant botulism: Constipation precedes motor symptoms by days; presents with weak cry, poor feeding, and "floppy baby syndrome"

TETANUS

• Clinical Diagnosis (Gold Standard) Based on Characteristic Presentation: Tetanus is primarily a clinical diagnosis lacking specific laboratory confirmation; diagnosis rests on recognition of the characteristic clinical syndrome in the setting of potential exposure history. The combination of trismus, risus sardonicus, opisthotonus, and rigidity in a patient with wound history or inadequate vaccination strongly suggests tetanus. The Ablett scoring system stratifies severity: Grade I (mild)—localized rigidity without spasms; Grade II (moderate)—generalized rigidity with mild spasms; Grade III (severe)—generalized rigidity with frequent violent spasms; Grade IV (very severe)—concurrent autonomic instability with hemodynamic lability.

• EMG Findings (Polyphonic Motor Unit Action Potentials): Electromyography shows characteristic polyphonic or "interference" pattern with normal motor conduction velocities and normal sensory studies. The EMG pattern reflects near-simultaneous contraction of motor units rather than the sequential recruitment seen in voluntary contraction, creating a distinctive "full interference" pattern at rest. While suggestive, EMG findings are non-specific and should not delay treatment if clinical suspicion is high.

• Elevated Creatine Kinase (CK) and Myoglobinuria: Severe tetanic spasms cause rhabdomyolysis with markedly elevated CK (often >1000 U/L) and myoglobinuria. CK elevation correlates with spasm severity and reflects muscle fiber damage from violent involuntary contractions. Myoglobinuria increases acute kidney injury risk and requires aggressive hydration for prevention.

• Organism Isolation (Rarely Successful): Clostridium tetani recovery from wounds is attempted but rarely successful, as symptoms result from circulating toxin rather than high bacterial burden. Anaerobic wound culture may occasionally grow the organism but is neither sensitive nor required for diagnosis.

• Toxin Detection (Research Only): Tetanospasmin detection in serum is not performed clinically and remains a research tool; clinical diagnosis supersedes any laboratory testing.

Immediate stabilisation (both diseases)

• Airway first: neuromuscular respiratory failure kills before the toxin is neutralised. In botulism, CDC's 2021 clinical guidelines advise serial bedside vital capacity and negative inspiratory force with elective intubation before decompensation; in tetanus, laryngospasm and truncal rigidity often force early intubation, and prolonged courses commonly lead to tracheostomy.
• Minimise stimulation in tetanus (quiet, darkened room, clustered care) because tactile, auditory, and visual stimuli trigger reflex spasms in a cord that has lost glycinergic/GABAergic inhibition.

Tetanus — first-line

• Human tetanus immune globulin (TIG): neutralises only unbound circulating toxin; toxin already internalised is irreversible, so give immediately on clinical suspicion (CDC/ACIP).
• Antimicrobials: nitroimidazole — metronidazole is CDC's preferred agent; penicillin G is an alternative but is itself a GABA-A antagonist and is theoretically pro-convulsant.
• Wound debridement: removes the anaerobic nidus of ongoing toxin production; do it after TIG where feasible.
• Benzodiazepines (diazepam, midazolam infusion): restore GABAergic inhibition, control spasms and provide sedation.

Tetanus — escalation

• Magnesium sulfate infusion: presynaptic calcium antagonism reduces spasms and catecholamine release; monitor patellar reflex for toxicity.
• Non-depolarising neuromuscular blockade (cisatracurium, vecuronium) with full ventilatory support for spasms refractory to sedation; intrathecal baclofen is a further option.
• Dysautonomia: labetalol or short-acting agents such as esmolol plus opioid (morphine) sedation. Avoid unopposed beta-blockade with propranolol — associated with sudden hypotension and death.
• Active immunisation: disease does not confer immunity; give age-appropriate Tdap/Td at a separate site and complete the series (ACIP).

Botulism — definitive therapy

• Heptavalent equine botulinum antitoxin (BAT/HBAT) for patients >1 year, released through the state health department and CDC; give on clinical grounds without waiting for stool, serum, or food testing, since antitoxin binds only free toxin.
• Human botulism immune globulin IV (BabyBIG), obtained from the California Department of Public Health, is the agent for infant botulism — not equine antitoxin.
• Wound botulism: surgical debridement plus penicillin G or metronidazole.

Contraindicated / avoid

• Aminoglycosides, clindamycin, and IV magnesium potentiate presynaptic blockade and worsen paralysis.
• Antibiotics in infant botulism: bacterial lysis releases additional intraluminal toxin.
• Delaying antitoxin for laboratory confirmation.

Emergencies (tetanus)

• Laryngospasm and acute asphyxia: spasm of the glottic and respiratory muscles; signalled by sudden stridor, desaturation, or inability to ventilate during a spasm. Requires immediate airway control — a true emergency.
• Autonomic storm / sudden cardiac arrest: loss of brainstem inhibition of sympathetic outflow produces labile hypertension alternating with abrupt hypotension, tachyarrhythmias, and asystole; heralded by wide swings in blood pressure and drenching diaphoresis in the second week. This is the leading cause of death in ICU-managed tetanus.
• Rhabdomyolysis with acute kidney injury: sustained agonist–antagonist co-contraction; signalled by markedly elevated CK, tea-coloured urine with heme-positive dipstick but few RBCs, and rising creatinine.

Other tetanus complications

• Vertebral compression fractures, long-bone fractures, tendon avulsion, tongue laceration: generated by the sheer force of tetanic contraction; new focal pain or deformity after a spasm is the clue.
• Aspiration and ventilator-associated pneumonia, venous thromboembolism, pressure injury: consequences of dysphagia, prolonged ventilation, and immobility.

Botulism

• Hypercapnic respiratory failure: descending paralysis of diaphragm and intercostals; the signal is a falling vital capacity or rising PaCO2 in an alert patient — do not wait for hypoxia. Emergency.
• Aspiration pneumonia from bulbar weakness and lost gag reflex.
• Prolonged ventilator dependence (weeks to months), since recovery requires axonal sprouting and new motor endplate formation.
• Ileus and urinary retention from parasympathetic cholinergic blockade; abdominal distension and bladder scan volumes are the tip-off.
• Relapse in wound botulism if the nidus is not debrided, because toxin production continues in vivo.

Treatment-related

• Equine antitoxin hypersensitivity: anaphylaxis during infusion (emergency — treat with intramuscular epinephrine 0.3 mg) and later serum sickness with fever, rash, and arthralgia days after.
• Magnesium toxicity: loss of deep tendon reflexes precedes respiratory depression.
• ICU-acquired weakness and prolonged sedation/withdrawal after days of benzodiazepine infusion and neuromuscular blockade.

• Same enzyme, opposite phenotype: both toxins are zinc endopeptidases cleaving SNARE proteins, but tetanospasmin ascends retrogradely to block inhibitory interneurons (rigid paralysis), while botulinum toxin stays at the peripheral cholinergic terminal (flaccid, descending paralysis). This mechanism contrast is the single most tested concept.
• Best next step is treat, not test: for suspected botulism, obtain the antitoxin through the state health department/CDC immediately — antitoxin binds only free toxin and cannot reverse paralysis already established (CDC 2021 guidelines). For tetanus, give TIG before debridement and start metronidazole.
• **Honey plus constipation plus *floppy baby*: infant botulism. The examiner wants BabyBIG (human-derived botulism immune globulin IV)** — equine heptavalent antitoxin and antibiotics are the wrong answers in infants; antibiotics lyse organisms and release more toxin.
• Descending vs ascending: botulism descends from cranial nerves caudally with intact sensation and dilated, poorly reactive pupils. Guillain–Barré ascends, has areflexia with paresthesias, and shows albuminocytologic dissociation in CSF. Botulism CSF is normal.
• Myasthenia gravis is the classic distractor: MG spares the pupils and shows a decremental response to slow repetitive nerve stimulation; botulism shows post-tetanic facilitation (incremental response) at high-frequency stimulation, because increased calcium partially overcomes presynaptic blockade.
• Tetanus rigidity persists during sleep and is not relieved by benztropine — that distinguishes it from an acute dystonic reaction to metoclopramide or antipsychotics. Strychnine poisoning mimics tetanus but the jaw relaxes fully between spasms.
• Surviving tetanus confers no immunity: the toxin dose that causes disease is too small to be immunogenic, so every patient needs age-appropriate Td/Tdap plus completion of the primary series per ACIP.
• Wound prophylaxis (ACIP): dirty/tetanus-prone wound with fewer than three prior doses or unknown history gets both the vaccine and TIG; a fully immunised patient needs only a booster based on interval since last dose.
• Avoid aminoglycosides, clindamycin, and IV magnesium in botulism — they worsen neuromuscular blockade. Botulism is also a notifiable condition and a Category A bioterrorism agent; report immediately.